NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus
- PMID: 19170166
- DOI: 10.1002/jnr.21998
NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus
Abstract
Alzheimer's disease (AD), the most common neurodegenerative disease in the elderly population, is characterized by the hippocampal deposition of fibrils formed by amyloid beta-protein (A beta), a 40- to 42-amino-acid peptide. The folding of A beta into neurotoxic oligomeric, protofibrillar, and fibrillar assemblies is believed to mediate the key pathologic event in AD. The hippocampus is especially susceptible in AD and early degenerative symptoms include significant deficits in the performance of hippocampal-dependent cognitive abilities such as spatial learning and memory. Transgenic mouse models of AD that express C-terminal segments or mutant variants of amyloid precursor protein, the protein from which A beta is derived, exhibit age-dependent spatial memory impairment and attenuated long-term potentiation (LTP) in the hippocampal CA1 and dentate gyrus (DG) regions. Recent experimental evidence suggests that A beta disturbs N-methyl-D-aspartic acid (NMDA) receptor-dependent LTP induction in the CA1 and DG both in vivo and in vitro. Furthermore, these studies suggest that A beta specifically interferes with several major signaling pathways downstream of the NMDA receptor, including the Ca(2+)-dependent protein phosphatase calcineurin, Ca(2+)/calmodulin-dependent protein kinase II (CaMKII), protein phosphatase 1, and cAMP response element-binding protein (CREB). The influence of A beta on each of these downstream effectors of NMDA is reviewed in this article. Additionally, other mechanisms of LTP modulation, such as A beta attenuation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents, are briefly discussed.
(c) 2009 Wiley-Liss, Inc.
Similar articles
-
Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice.J Neurochem. 2006 Apr;97(1):22-9. doi: 10.1111/j.1471-4159.2006.03710.x. Epub 2006 Mar 3. J Neurochem. 2006. PMID: 16515554
-
Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus.Neurobiol Learn Mem. 2002 May;77(3):354-71. doi: 10.1006/nlme.2001.4034. Neurobiol Learn Mem. 2002. PMID: 11991763
-
Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory.Neurobiol Dis. 2008 Aug;31(2):250-60. doi: 10.1016/j.nbd.2008.04.011. Epub 2008 May 10. Neurobiol Dis. 2008. PMID: 18585048
-
Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.Brain Res Brain Res Rev. 2004 Dec;47(1-3):275-89. doi: 10.1016/j.brainresrev.2004.07.018. Brain Res Brain Res Rev. 2004. PMID: 15572177 Review.
-
Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.Biochem Soc Trans. 2005 Aug;33(Pt 4):563-7. doi: 10.1042/BST0330563. Biochem Soc Trans. 2005. PMID: 16042545 Review.
Cited by
-
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes.Nat Neurosci. 2012 Jan 29;15(3):349-57. doi: 10.1038/nn.3028. Nat Neurosci. 2012. PMID: 22286176 Review.
-
Postsynaptic Receptors for Amyloid-β Oligomers as Mediators of Neuronal Damage in Alzheimer's Disease.Front Physiol. 2012 Dec 20;3:464. doi: 10.3389/fphys.2012.00464. eCollection 2012. Front Physiol. 2012. PMID: 23267328 Free PMC article.
-
Crucial role of calbindin-D28k in the pathogenesis of Alzheimer's disease mouse model.Cell Death Differ. 2014 Oct;21(10):1575-87. doi: 10.1038/cdd.2014.67. Epub 2014 May 23. Cell Death Differ. 2014. PMID: 24853300 Free PMC article.
-
Reducing amyloid-related Alzheimer's disease pathogenesis by a small molecule targeting filamin A.J Neurosci. 2012 Jul 18;32(29):9773-84. doi: 10.1523/JNEUROSCI.0354-12.2012. J Neurosci. 2012. PMID: 22815492 Free PMC article.
-
Association among amyloid plaque, lipid, and creatine in hippocampus of TgCRND8 mouse model for Alzheimer disease.J Biol Chem. 2010 Oct 8;285(41):31202-7. doi: 10.1074/jbc.M110.142174. Epub 2010 Aug 3. J Biol Chem. 2010. PMID: 20682779 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous